Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])

This publication has 25 references indexed in Scilit:

• A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease Patients
  The Journal of Clinical Hypertension, 2005
• Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?
  Diabetes Care, 2005
• Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance
  Diabetes Care, 2005
• Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study
  Hypertension, 2004
• Cardiovascular Therapies and Risk for Development of Diabetes
  Journal of the American College of Cardiology, 2004
• Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
  Hypertension, 2004
• A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
  JAMA, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension
  Journal of the American College of Cardiology, 1998
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Archives of internal medicine (1960), 1997